MethylGene, EnVivo enter deal with non-profit company
In this collaboration, CHDI will provide financial and preclinical research support to enhance the collaboration between MethylGene and EnVivo in order to progress histone deacetylase (HDAC) inhibitors for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.